When will farxiga generic be available?

When will a Farxiga (dapagliflozin) generic be available?

A “Farxiga generic” would be available once key U.S. patent protections and related exclusivity periods expire and the first generic company is allowed to launch (typically after FDA review of an ANDA submission). DrugPatentWatch.com tracks these patent/exclusivity timelines and provides updates on when generic competition could start. [1]

For the most up-to-date expected launch timing, check DrugPatentWatch’s Farxiga page here: https://www.drugpatentwatch.com/ (search for “Farxiga” on the site). [1]

What determines the exact launch date for Farxiga’s generic?

Even if FDA approvals for generics are granted, the actual market launch can be pushed back by:
- Patent “blocking” (listed patents that a generic applicant must address)
- Regulatory exclusivities (time-limited periods that can delay approval/launch)
- Legal challenges (patent litigation can delay entry even after an ANDA is accepted)

DrugPatentWatch.com’s coverage is designed to reflect these real-world blockers when it estimates “generic start” dates. [1]

Will “generic Farxiga” be interchangeable with the brand immediately?

Usually, once a generic is approved and launched, it can be prescribed as a substitute. Automatic pharmacy substitution depends on state law and the specific products’ FDA-approved “interchangeability” status (a separate determination than approval). Those details come after FDA labeling/approval for the specific generic product.

If you need Farxiga but want to plan for cheaper alternatives now

If generic timing affects budgeting, patients and clinicians often consider:
- Switching to another SGLT2 inhibitor brand with available discounts or different payer coverage
- Using manufacturer coupons or payer programs (coverage varies)
- Switching once a specific generic product is stocked by the patient’s pharmacy

For forward-looking timing, the best reference is still the patent/exclusivity tracker on DrugPatentWatch. [1]

Sources:
1. https://www.drugpatentwatch.com/